Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 08 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-1.11 Insider Own5.33% Shs Outstand77.20M Perf Week35.07%
Market Cap287.50M Forward P/E- EPS next Y-1.05 Insider Trans0.13% Shs Float75.19M Perf Month46.86%
Income-67.06M PEG- EPS next Q-0.34 Inst Own51.07% Short Float / Ratio7.73% / 6.55 Perf Quarter-6.70%
Sales57.72M P/S4.98 EPS this Y-11.96% Inst Trans-3.19% Short Interest5.81M Perf Half Y-51.28%
Book/sh0.10 P/B36.61 EPS next Y-1.94% ROA-41.79% Target Price12.25 Perf Year29.29%
Cash/sh1.39 P/C2.60 EPS next 5Y- ROE-247.99% 52W Range2.00 - 7.96 Perf YTD28.83%
Dividend- P/FCF- EPS past 5Y15.93% ROI-75.35% 52W High-54.52% Beta0.86
Dividend %- Quick Ratio3.96 Sales past 5Y119.20% Gross Margin91.50% 52W Low81.45% ATR0.30
Employees274 Current Ratio4.03 Sales Q/Q26.04% Oper. Margin-141.54% RSI (14)70.23 Volatility13.08% 10.66%
OptionableYes Debt/Eq10.58 EPS Q/Q19.38% Profit Margin-116.18% Rel Volume1.14 Prev Close3.72
ShortableYes LT Debt/Eq10.34 EarningsNov 07 AMC Payout- Avg Volume887.65K Price3.62
Recom1.38 SMA2042.52% SMA5036.52% SMA200-19.36% Volume1,014,847 Change-2.69%
Date Action Analyst Rating Change Price Target Change
Apr-21-23Initiated Robert W. Baird Outperform $18
Aug-10-22Resumed Berenberg Buy $15
Aug-10-21Upgrade H.C. Wainwright Neutral → Buy $17
Dec-28-20Downgrade H.C. Wainwright Buy → Neutral
Dec-17-20Initiated Berenberg Buy $27
Nov-13-20Reiterated Raymond James Strong Buy $15 → $25
Aug-10-20Reiterated H.C. Wainwright Buy $10 → $13
Mar-03-20Upgrade Raymond James Outperform → Strong Buy
May-21-19Reiterated H.C. Wainwright Buy $12 → $9
May-21-19Downgrade Raymond James Strong Buy → Outperform $11 → $5
Nov-08-23 05:18PM
Nov-07-23 06:47PM
Nov-01-23 08:00AM
07:06AM Loading…
Oct-31-23 09:00AM
Oct-30-23 09:35PM
Oct-24-23 08:00AM
Oct-03-23 04:01PM
Sep-19-23 09:00PM
Sep-06-23 08:00AM
Aug-09-23 08:00AM
Aug-08-23 11:13AM
Aug-07-23 07:15PM
06:05PM Loading…
Jul-24-23 08:00AM
Jul-14-23 06:59AM
Jul-13-23 09:00AM
Jul-12-23 08:00AM
Jun-10-23 06:30PM
Jun-07-23 08:00AM
Jun-05-23 04:01PM
Jun-02-23 09:37AM
Jun-01-23 08:00AM
May-09-23 11:42AM
May-08-23 06:15PM
04:01PM Loading…
May-04-23 09:50AM
Apr-28-23 08:00AM
Apr-24-23 08:00AM
Apr-14-23 04:01PM
Apr-07-23 08:49AM
Mar-11-23 07:22AM
Mar-08-23 08:50AM
Mar-07-23 08:40AM
Mar-06-23 05:15PM
Feb-28-23 08:00AM
Feb-27-23 05:15PM
Feb-21-23 08:00AM
Feb-16-23 05:15PM
Feb-13-23 05:52AM
Feb-11-23 08:00AM
Jan-06-23 08:00AM
Dec-24-22 07:34AM
Nov-13-22 07:10AM
Nov-08-22 08:00AM
Nov-07-22 05:25PM
Oct-24-22 06:00AM
Oct-17-22 08:11AM
Sep-30-22 09:27AM
Sep-27-22 10:21AM
Sep-22-22 07:00AM
Sep-07-22 04:01PM
Aug-10-22 08:00AM
Aug-08-22 05:45PM
Jul-25-22 08:00AM
Jul-13-22 01:58PM
Jun-13-22 01:23PM
Jun-08-22 07:00AM
Jun-01-22 08:00AM
May-13-22 06:03AM
May-09-22 05:45PM
May-03-22 05:35PM
Apr-26-22 08:00AM
Apr-25-22 08:00AM
Apr-14-22 04:35PM
Apr-12-22 10:46PM
Mar-04-22 08:00AM
Mar-02-22 07:28AM
Feb-28-22 05:35PM
Feb-23-22 06:05PM
Feb-22-22 08:00AM
Feb-11-22 08:00AM
Jan-18-22 08:00AM
Jan-12-22 09:38AM
Jan-04-22 08:00AM
Dec-06-21 07:00AM
Nov-20-21 06:09AM
Nov-15-21 08:00AM
Nov-09-21 01:17PM
Nov-08-21 07:35PM
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mattessich Antony C.President and CEOAug 30Buy3.816,50024,7656,500Sep 05 08:27 AM
Ozden Rabia GursesChief Medical OfficerJul 07Sale4.938324,102100,531Jul 11 08:00 PM
Mattessich Antony C.President and CEOFeb 06Sale4.2419,66983,397446,281Feb 08 07:29 PM
Notman DonaldChief Financial OfficerFeb 06Sale4.246,47627,458139,387Feb 08 07:32 PM
Ozden Rabia GursesChief Medical OfficerFeb 06Sale4.246,41627,204101,363Feb 08 07:33 PM
Strassburger Philip C.General CounselFeb 06Sale4.246,18126,207109,071Feb 08 07:31 PM
White Christopher GChief Business OfficerFeb 06Sale4.245,82924,71594,766Feb 08 07:38 PM